Medicare Enrolled

Dr. Ryan Miyamoto, MD

Urology Physician · Pensacola, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
125 BAPTIST WAY STE 4B, Pensacola, FL 32503
4482276350
In practice since 2008 (18 years)
NPI: 1245415454 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Miyamoto from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miyamoto? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Miyamoto

Dr. Ryan Miyamoto is an urology physician in Pensacola, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Miyamoto performed 823 Medicare services across 677 unique beneficiaries.

Between the years covered by Open Payments, Dr. Miyamoto received a total of $2,541 from 33 pharmaceutical and/or device companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Miyamoto is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 823 Medicare services $2,541 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 126100 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
823
Medicare services
Bottom 33% in FL for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
677
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~46 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 195 $70 $107
Office visit, established patient (20-29 min) 185 $45 $71
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant 52 $39 $65
New patient office visit (45-59 min) 40 $84 $165
Office visit, established patient, complex (40-54 min) 37 $104 $149
Biopsy of prostate gland 34 $96 $175
Ultrasonic guidance for needle placement 33 $23 $70
Initial hospital admission, moderate complexity 33 $105 $280
Limited ultrasound scan of abdomen 32 $21 $90
Diagnostic exam of bladder and urethra using an endoscope 26 $63 $130
Ultrasound scan of pelvic region through rectum 26 $24 $105
Exam with injections of chemical for destruction of bladder using an endoscope 21 $120 $360
Insertion of stent in ureter using an endoscope 19 $105 $452
Removal of lymph nodes of both sides of pelvis using an endoscope 15 $269 $1,410
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope 15 $583 $1,775
Surgical removal of prostate and surrounding lymph nodes using an endoscope 14 $953 $3,030
Crushing of stone of ureter with insertion of stent using an endoscope 12 $277 $880
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant 12 $161 $270
Placement of device in prostate for radiation therapy 11 $41 $135
New patient office visit, complex (60-74 min) 11 $127 $220
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.8% high complexity
15.1% medium
81.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,541
Total received (2018-2024)
Avg $363/year across 7 years
Bottom 41% in FL for urology physician
33
Companies
132
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,528 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$404
2023
$677
2022
$430
2021
$11
2020
$55
2019
$538
2018
$425

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$406
Sumitomo Pharma America, Inc.
$290
Endo Pharmaceuticals Inc.
$209
Medtronic, Inc.
$204
Astellas Pharma US Inc
$144
Coloplast Corp
$137
Boston Scientific Corporation
$126
Olympus America Inc.
$126
ABBVIE INC.
$101
Allergan Inc.
$91
PFIZER INC.
$86
Medtronic USA, Inc.
$47
NeoTract Inc.
$45
Progenics Pharmaceuticals, Inc.
$41
DAVOL INC.
$41
Allergan, Inc.
$38
UroGen Pharma, Inc.
$38
Osiris Therapeutics Inc.
$36
UROVANT SCIENCES INC
$35
Ferring Pharmaceuticals Inc.
$33
ABC Home Medical Supply, Inc.
$31
Egalet US Inc
$28
AbbVie, Inc.
$27
ROCHESTER MEDICAL CORPORATION
$26
EDAP TECHNOMED INC
$21
180 Medical, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$19
Novartis Pharmaceuticals Corporation
$17
Rochester Medical Corporation
$17
Tolmar, Inc.
$16
Endo USA, Inc.
$16
C. R. BARD, INC. & SUBSIDIARIES
$15
AMAG Pharmaceuticals, Inc.
$13
Top 3 companies account for 35.6% of total payments
Associated products mentioned in payments ›
ADVANTAGE FIT · AVEED · AVYCAZ · Androgel · BOTOX · BOTOX THERAPEUTIC · Bovie · CYSTO-NEPHRO VIDEOSCOPE · ELIGARD · ERLEADA · Erleada · GEMTESA · GENTLECATH · GRAFIX/GRAFIXPL/STRAVIX · INTERSTIM · INTRAROSA · JELMYTO · LithoVue · Lupron · MYRBETRIQ · Myrbetriq · NOCDURNA · NURO · ORGOVYX · Olympus Cysto-Resection · PROGEL · PYLARIFY · RETRACE · SPRIX · SpeediCath · TITAN · TOVIAZ · UroLift · VESICARE · XIAFLEX · XTANDI · Xofigo · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $309 per 100 Medicare services performed
Looking for an urology physician in Pensacola?
Compare urology physicians in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
19
Per 100K population
5.9
County median income
$65,715
Nearest hospital
BAPTIST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Miyamoto is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Miyamoto experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Miyamoto performed 195 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Miyamoto receive payments from pharmaceutical companies?
Yes. Dr. Miyamoto received a total of $2,541 from 33 companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miyamoto's costs compare to other urology physicians in Pensacola?
Dr. Miyamoto's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miyamoto) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →